Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2002;91:390-397
Published online before print August 15, 2002, doi: 10.1161/01.RES.0000033524.92083.64
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
91/5/390    most recent
01.RES.0000033524.92083.64v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chang, Y.
Right arrow Articles by Hassid, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chang, Y.
Right arrow Articles by Hassid, A.
Related Collections
Right arrow Cell signalling/signal transduction
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Other Vascular biology
(Circulation Research. 2002;91:390.)
© 2002 American Heart Association, Inc.


Molecular Medicine

Nitric Oxide–Induced Motility in Aortic Smooth Muscle Cells

Role of Protein Tyrosine Phosphatase SHP-2 and GTP-Binding Protein Rho

Yingzi Chang, Bogdan Ceacareanu, Madhulika Dixit, Nair Sreejayan, Aviv Hassid

From the Department of Physiology and Vascular Biology Center, University of Tennessee, Memphis.

Correspondence to Aviv Hassid, PhD, Department of Physiology, University of Tennessee, 894 Union Ave, Memphis, TN 38163. E-mail ahassid{at}physio1.utmem.edu

We have previously reported that SHP-2 upregulation is necessary for NO-stimulated motility in differentiated rat aortic smooth muscle cells. We now test the hypothesis that upregulation of SHP-2 is necessary and sufficient to stimulate cell motility. Overexpression of SHP-2 via recombinant adenoviral vector stimulated motility to the same extent as NO, whereas the expression of C463S-SHP-2, the dominant-negative SHP-2 allele, blocked the motogenic effect of NO. On the basis of previous studies, we next tested the hypothesis that NO decreases RhoA activity and that this event is necessary and sufficient to explain NO-induced motogenesis. We found that NO decreased RhoA activity in a concentration-dependent manner. Moreover, a dominant-negative SHP-2 allele, DSH2, blocked the NO-induced inhibition of RhoA activity, indicating that upregulation of SHP-2 is necessary for this event. Expression of G14V-RhoA, the constitutively active RhoA allele, decreased cell motility and blocked the motogenic effect of NO, whereas the expression of T19N-RhoA, the dominant-negative RhoA allele, increased cell motility to an extent similar to that induced by NO. Dominant-negative RhoA reversed the effect of dominant-negative SHP-2, indicating that RhoA functions downstream from SHP-2. To investigate events downstream from RhoA, we treated cells with fasudil, a selective Rho kinase inhibitor, and found that it increased cell motility. These results indicate that upregulation of SHP-2, leading to downregulation of RhoA, which is followed by decreased Rho kinase activity, is a sequence of events necessary and sufficient to explain NO-induced cell motility in differentiated aortic smooth muscle cells. The results may be of relevance to in vivo events such as neointimal formation, angiogenesis, and vasculogenesis.


Key Words: nitric oxide • SHP-2 • Rho • cell motility




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Zhuang, Q. Pu, B. Ceacareanu, Y. Chang, M. Dixit, and A. Hassid
Chronic insulin treatment amplifies PDGF-induced motility in differentiated aortic smooth muscle cells by suppressing the expression and function of PTP1B
Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H163 - H173.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. I. Kontaridis, W. Yang, K. K. Bence, D. Cullen, B. Wang, N. Bodyak, Q. Ke, A. Hinek, P. M. Kang, R. Liao, et al.
Deletion of Ptpn11 (Shp2) in Cardiomyocytes Causes Dilated Cardiomyopathy via Effects on the Extracellular Signal-Regulated Kinase/Mitogen-Activated Protein Kinase and RhoA Signaling Pathways
Circulation, March 18, 2008; 117(11): 1423 - 1435.
[Abstract] [Full Text] [PDF]


Home page
Arch DermatolHome page
A. Du-Thanh, H. Cave, D. Bessis, C. Puso, J.-J. Guilhou, and O. Dereure
A Novel PTPN11 Gene Mutation in a Patient With LEOPARD Syndrome
Arch Dermatol, September 1, 2007; 143(9): 1210 - 1211.
[Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
S. Cetin, C. L. Leaphart, J. Li, I. Ischenko, M. Hayman, J. Upperman, R. Zamora, S. Watkins, H. R. Ford, J. Wang, et al.
Nitric oxide inhibits enterocyte migration through activation of RhoA-GTPase in a SHP-2-dependent manner
Am J Physiol Gastrointest Liver Physiol, May 1, 2007; 292(5): G1347 - G1358.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
M.G. Ferrini, I. Kovanecz, S. Sanchez, D. Vernet, H.H. Davila, J. Rajfer, and N.F. Gonzalez-Cadavid
Long-Term Continuous Treatment with Sildenafil Ameliorates Aging-Related Erectile Dysfunction and the Underlying Corporal Fibrosis in the Rat
Biol Reprod, May 1, 2007; 76(5): 915 - 923.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. S. Isenberg, D. A. Wink, and D. D. Roberts
Thrombospondin-1 antagonizes nitric oxide-stimulated vascular smooth muscle cell responses
Cardiovasc Res, September 1, 2006; 71(4): 785 - 793.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Rafiq, M. A. Kolpakov, M. Abdelfettah, D. N. Streblow, A. Hassid, L. J. Dell'Italia, and A. Sabri
Role of Protein-tyrosine Phosphatase SHP2 in Focal Adhesion Kinase Down-regulation during Neutrophil Cathepsin G-induced Cardiomyocytes Anoikis
J. Biol. Chem., July 14, 2006; 281(28): 19781 - 19792.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
A.-C. Ceacareanu, B. Ceacareanu, D. Zhuang, Y. Chang, R. M. Ray, L. Desai, K. E. Chapman, C. M. Waters, and A. Hassid
Nitric oxide attenuates IGF-I-induced aortic smooth muscle cell motility by decreasing Rac1 activity: essential role of PTP-PEST and p130cas
Am J Physiol Cell Physiol, April 1, 2006; 290(4): C1263 - C1270.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
G. Loirand, P. Guerin, and P. Pacaud
Rho Kinases in Cardiovascular Physiology and Pathophysiology
Circ. Res., February 17, 2006; 98(3): 322 - 334.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
R. N. Kumar, J. H. Ha, R. Radhakrishnan, and D. N. Dhanasekaran
Transactivation of Platelet-Derived Growth Factor Receptor {alpha} by the GTPase-Deficient Activated Mutant of G{alpha}12
Mol. Cell. Biol., January 1, 2006; 26(1): 50 - 62.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. I. Palen, S. Belmadani, P. A. Lucchesi, and K. Matrougui
Role of SHP-1, Kv.1.2, and cGMP in nitric oxide-induced ERK1/2 MAP kinase dephosphorylation in rat vascular smooth muscle cells
Cardiovasc Res, November 1, 2005; 68(2): 268 - 277.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Heo and S. L. Campbell
Mechanism of Redox-mediated Guanine Nucleotide Exchange on Redox-active Rho GTPases
J. Biol. Chem., September 2, 2005; 280(35): 31003 - 31010.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. S. Lee, N. Kang Decker, S. Chatterjee, J. Yao, S. Friedman, and V. Shah
Mechanisms of Nitric Oxide Interplay with Rho GTPase Family Members in Modulation of Actin Membrane Dynamics in Pericytes and Fibroblasts
Am. J. Pathol., June 1, 2005; 166(6): 1861 - 1870.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Chang, D. Zhuang, C. Zhang, and A. Hassid
Increase of PTP levels in vascular injury and in cultured aortic smooth muscle cells treated with specific growth factors
Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H2201 - H2208.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Wakino, K. Hayashi, T. Kanda, S. Tatematsu, K. Homma, K. Yoshioka, I. Takamatsu, and T. Saruta
Peroxisome Proliferator-Activated Receptor {gamma} Ligands Inhibit Rho/Rho Kinase Pathway by Inducing Protein Tyrosine Phosphatase SHP-2
Circ. Res., September 3, 2004; 95(5): e45 - e55.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Zhuang, A.-C. Ceacareanu, Y. Lin, B. Ceacareanu, M. Dixit, K. E. Chapman, C. M. Waters, G. N. Rao, and A. Hassid
Nitric oxide attenuates insulin- or IGF-I-stimulated aortic smooth muscle cell motility by decreasing H2O2 levels: essential role of cGMP
Am J Physiol Heart Circ Physiol, June 1, 2004; 286(6): H2103 - H2112.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Dixit, D. Zhuang, B. Ceacareanu, and A. Hassid
Treatment With Insulin Uncovers the Motogenic Capacity of Nitric Oxide in Aortic Smooth Muscle Cells: Dependence on Gab1 and Gab1-SHP2 Association
Circ. Res., November 14, 2003; 93 (10): e113 - e123.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
P. M. Martin, A. E. Sutherland, and L. J. Van Winkle
Amino Acid Transport Regulates Blastocyst Implantation
Biol Reprod, October 1, 2003; 69(4): 1101 - 1108.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Lin, A. C. Ceacareanu, and A. Hassid
Nitric oxide-induced inhibition of aortic smooth muscle cell motility: role of PTP-PEST and adaptor proteins p130cas and Crk
Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H710 - H721.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
B. Wojciak-Stothard and A. J. Ridley
Shear stress-induced endothelial cell polarization is mediated by Rho and Rac but not Cdc42 or PI 3-kinases
J. Cell Biol., April 28, 2003; 161(2): 429 - 439.
[Abstract] [Full Text] [PDF]